Differential Role of Transient Receptor Potential Channels in Ca2+ Entry and Proliferation of Prostate Cancer Epithelial Cells

Stéphanie Thebault(Inserm), Matthieu Flourakis(Inserm), Karine Vanoverberghe(Inserm), Franck Vandermoere(Laboratoire de Biologie du Développement), Morad Roudbaraki(Inserm), V’yacheslav Lehen’kyi(Inserm), Christian Slomianny(Inserm), Benjamin Beck(Inserm), Pascal Mariot(Inserm), J Bonnal(Inserm), Brigitte Mauroy(Inserm), Yaroslav M. Shuba(Inserm), Thierry Capiod(Inserm), Roman Skryma(Inserm), Natalia Prevarskaya(Inserm)
Cancer Research
February 15, 2006
Cited by 201Open Access
Full Text

Abstract

One major clinical problem with prostate cancer is the cells' ability to survive and proliferate upon androgen withdrawal. Because Ca2+ is central to growth control, understanding the mechanisms of Ca2+ homeostasis involved in prostate cancer cell proliferation is imperative for new therapeutic strategies. Here, we show that agonist-mediated stimulation of alpha1-adrenergic receptors (alpha1-AR) promotes proliferation of the primary human prostate cancer epithelial (hPCE) cells by inducing store-independent Ca2+ entry and subsequent activation of nuclear factor of activated T cells (NFAT) transcription factor. Such an agonist-induced Ca2+ entry (ACE) relied mostly on transient receptor potential canonical 6 (TRPC6) channels, whose silencing by antisense hybrid depletion decreased both hPCE cell proliferation and ACE. In contrast, ACE and related growth arrest associated with purinergic receptors (P2Y-R) stimulation involved neither TRPC6 nor NFAT. Our findings show that alpha1-AR signaling requires the coupled activation of TRPC6 channels and NFAT to promote proliferation of hPCE cells and thereby suggest TRPC6 as a novel potential therapeutic target.


Related Papers

No related papers found

Powered by citation graph analysis